NEW YORK--(BUSINESS WIRE)-- The Board of Directors of Bristol-Myers Squibb Company (NYSE:BMY) today declared a 3% percent increase in the company’s quarterly dividend, beginning in the first quarter of 2012.
The dividend increase will result in a quarterly dividend of thirty-four cents ($0.34) per share on the $.10 par value Common Stock of the corporation for an indicative 2012 full-year dividend of $1.36 per share, subject to the normal quarterly review by the Board. The next quarterly dividend will be payable on February 1, 2012, to stockholders of record at the close of business on January 6, 2012.
The Directors also declared a quarterly dividend of fifty cents ($0.50) per share on the $2.00 Convertible Preferred Stock of the corporation, payable March 1, 2012, to stockholders of record at the close of business on February 3, 2012.
About Bristol-Myers Squibb
Bristol-Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. For more information, please visit www.bms.com or follow us on Twitter at http://twitter.com/bmsnews.
KEYWORDS: United States North America New York
INDUSTRY KEYWORDS: Health Biotechnology Pharmaceutical Research Science